adMare Bio Innovations logo

adMare Bio Innovations

North America, British Columbia, Canada, Vancouver

Description

adMare Bio innovations is a global life sciences venture, building Canadian life sciences from sea to sea.

Investor Profile

adMare Bio Innovations has made 7 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (29%)
  • Series B (29%)
  • Series A (14%)
  • Convertible Note (14%)
  • Series C (14%)

Country Focus

  • Canada (71%)
  • United Kingdom (14%)
  • France (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does adMare Bio Innovations frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 4
MaRS Investment Accelerator Fund
North America, Ontario, Canada, Toronto
Co-Investments: 1
Amorchem
North America, Quebec, Canada, Montréal
Co-Investments: 2
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 3
Investissement Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 3
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 2

Which angels does adMare Bio Innovations often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by adMare Bio Innovations?

KisoJi Biotechnology

Laval-ouest, Quebec, Canada

KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.

BiotechnologyLife ScienceMedicalTherapeutics
Series BDec 2, 2024
Amount Raised: $40,579,533
Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedOct 24, 2024
Amount Raised: $31,000,000
Find therapeutics

Quebec, Quebec, Canada

Find therapeutics is operator of a drug discovery and development company intended to emerge with a new therapeutic modality.

Biotechnology
Convertible NoteSep 16, 2024
Amount Raised: $8,095,825
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series COct 17, 2022
Amount Raised: $69,264,701
Domain Therapeutics

Illkirch, Alsace, France

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AMay 10, 2022
Amount Raised: $41,063,697
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BSep 8, 2020
Amount Raised: $35,000,000
Bright Angel Therapeutics

Toronto, Ontario, Canada

Bright Angel Therapeutics is developing new drugs that can prevent or revert the emergence of antifungal resistance.

Biotechnology
SeedDec 3, 2019